Low-Protein Rice (LPR) Product: Processing Method and Product Safety
DOI:
https://doi.org/10.17140/aftnsoj-3-142Keywords:
Chronic kidney disease (CKD), Low-protein diet (LPD), Low-protein rice (LPR), Dietary therapyAbstract
Background: Dietary therapy through a low-protein diet (LPD) has long been used for preserv-ing the renal function of patients with chronic kidney disease (CKD). Reducing the amount of protein ingested from rice would make it possible to allocate the difference to side dishes, thereby improving the quality of meals and facilitating adherence to LPD.
Methods: Forica Foods Co., Ltd., Uonuma City, Niigata, Japan developed exclusive technology in 1994 for obtaining low-protein rice (LPR), using proteolytic enzymes to digest and remove the protein in white rice. In 2004, we developed processing technology to enhance the palat-ability of said LPR. By combining these technologies, we established a manufacturing method for producing delicious, high quality processed rice products which can serve as a daily staple.
Results: For more than two decades since being launched in 1995, nearly 100 million Protein Low Content (PLC) rice products have been sold, and to date, there have been zero complaints of health problems attributable to them. This demonstrates their high safety even when eaten repeatedly over a long period.
Discussion: The PLC Rice series of products, which compare favorably with, and can be sub-stituted for, regular rice, are delicious (high quality) enough to be eaten everyday. They enhance the quality of mealtimes for CKD patients by increasing their range of food choices.
Conclusion: PLC Rice product offers high added value, as they not only facilitate adhesion to LPD but also add satisfaction and contentment to daily meals, helping to enhance the quality of life (QoL) of patients with CKD.
References
Beale LS. Kidney Diseases, Urinary Deposits and Calculous Disorders, Their Nature and Treatment. Philadelphia, PA, USA: Lindsay and Blakiston; 1869
Giordano C. Use of exogenous and endogenous urea for protein synthesis in normal and uremic subjects. J Lab Clin Med. 1963; 62: 545-577
Giovannetti S, Maggiore Q. A low-nitrogen diet with proteins of high biological value for severe chronic uremia. Lancet. 1964; 1(7341): 1000-1003
Maroni BJ, Steinman TI, Mitch WE. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int. 1985; 27(1): 58-65. doi: 10.1038/ki.1985.10
King AJ, Levey AS. Dietary protein and renal function. J Am Soc Nephrol. 1993; 3(11): 1723-1737
Watanabe S. Low-protein diet for the prevention of renal failure. Proc Jpn Acad Ser B. 2017; 93: 1-9. doi: 10.2183/ pjab.93.001 Figure 7: Nutrient Content in “Cooked PLC Rice” Series. 168 160 162 162 160 160 0 50 100 150 200 WR 1/3 1/5 1/10 1/20 1/25 Energy (kcal/100 g product) 2.5 0.87 0.44 0.24 0.13 0.10 0 1 2 3 WR 1/3 1/5 1/10 1/20 1/25 Protein content (g/100 g product) 29 0.6 0.5 0.9 0.6 0.7 0 10 20 30 40 WR 1/3 1/5 1/10 1/20 1/25 Potassium contennt (mg/100 g product) 34 15 15 14 13 13 0 10 20 30 40 WR 1/3 1/5 1/10 1/20 1/25 Phosphorus content (mg/100 g product) Open Journal ADVANCES IN FOOD TECHNOLOGY AND NUTRITIONAL SCIENCES Adv Food Technol Nutr Sci Open J Page 41
Walser M, Mitch WE, Maroni BJ, Kopple JD. Should protein intake be restricted in predialysis patients? Kidney Int. 1999; 55(3): 771-777. doi: 10.1046/j.1523-1755.1999.055003771.x
Egawa K, Shishido K. Japan Patent JP2706888B (1994.10.17)
Takahara J, Nakajo M. Japan Patent JP3156902B (2001.2.9)
Takei N, Watanabe N, Nakajo M. WO2017037799A1 (2015.8.28)
Ideura T, Shimazui M, Morita H, Yoshimura A. Protein intake of more than 0.5 g/kg BW/day is not effective in suppressing the progression of chronic renal failure. Contrib Nephrol. 2007; 155: 45-49. doi: 10.1159/000100995
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Advances in Food Technology and Nutrition Sciences (AFTNS) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.